dismiss

Clean Sweep Live Auction on Wed. February 27th. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
Advertisement

 

advertisement

 

Cardiology Homepage

John D. Zehren Endologix appoints chief commercial officer

Medtronic to acquire EPIX Therapeutics Will use EPIX's cardiac ablation technology with Medtronic's cryoballoon technology

Centerline Biomedical submits IOPS system for FDA clearance Designed as alternative to X-ray fluoroscopy

Philips unveils Azurion angiography system with FlexArm positioning System moves on eight different axes with single controller

FDA clears RFPi's iCertainty blood flow and perfusion imaging solution No injections, dyes, radiation, direct patient contact or interruptions in procedures

Rob Beanlands ASNC names president for 2019

FDA gives nod to new clearance for iSchemaView’s RAPID platform Can help select which stroke patients require clot removal procedures

Hill-Rom Holdings launches LINQ Mobile App that connects care team members to one another, patients and patient info in real time

FDA gives green light for Edwards' SAPIEN 3 Ultra system Provides transcatheter aortic valve replacement to patients facing surgical risks

Boston Scientific to acquire shares of Millipede for $325 million Initially bought $90 million worth of shares a year ago

Keith D. Dawkins

Keith D. Dawkins

InnovHeart elects chairman of the board
September 13, 2018
MILAN, Italy, Sept. 6, 2018 /PRNewswire/ -- InnovHeart s.r.l., a privately-held, venture-backed developer of transcatheter-delivered mitral valve replacement systems (TMVR) for the treatment of mitral valve disease, announced today that it has appointed veteran medical device executive Keith D. Dawkins, M.D., as Chairman of its Board of Directors.

Dr. Dawkins is transitioning from his position as a member of the InnovHeart Board which he joined in May of this year. Dr. Dawkins has more than 35 years experience as both a practicing physician and an executive within the medical device industry. He currently also serves at 4Tech Inc. as Chief Medical Officer, and as a member of the Boards of Avicena LLC and JenaValve Technology Inc. Dr. Dawkins previously served as Executive Vice President and Global Chief Medical Officer at Boston Scientific for all divisions, 2012 – 2017. His responsibilities included enhancing the company's global clinical programs and strategies. Before that, he served as Senior Vice President and CMO for the Boston Scientific Cardiology Rhythm and Vascular Group. Prior to joining Boston Scientific, Dr. Dawkins was a practicing interventional cardiologist for over 20 years in the U.K. He has earned a series of clinical, research and academic distinctions, including a post-doctoral research fellowship at Stanford University as a Fulbright Scholar. Dr. Dawkins also served as President of the British Cardiovascular Intervention Society, and held numerous appointments on hospital, regional and national committees, including the National Institute for Health and Clinical Excellence (NICE). He has been an author on more than 750 academic publications and presentations on a variety of cardiac topics.

Story Continues Below Advertisement

Has exclusive distribution agreement with DDD to sell new Camera systems

UMRi provides the very best new & refurbished gamma cameras, quality parts &repair services. We also rebuild & replace camera detectors, move camera systems across town or across the country. Call us at 888-239-3510



InnovHeart's CEO, Giovanni Righini, welcomed Keith Dawkins' appointment: "Keith has brought a wealth of experience and expertise to the InnovHeart Board and he has the ideal profile to lead the next strategic phase for the Saturn TMVR project. I look forward to working even closer with him for the full realization of our goals."

"TMVR is the next exciting opportunity in the minimally-invasive structural heart space. Significant challenges remain, but the unique features of the Saturn valve offer patients a valid alternative to conventional mitral valve surgery. It is a privilege to lead the InnovHeart Board in this exciting endeavor," said Dr. Dawkins.


About InnovHeart's Saturn System
The Saturn System is a catheter-based mitral valve implantation system, engineered for
  Pages: 1 - 2 >>

Cardiology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED